NCT01030341

Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis

Pilot Study of the Safety, Feasibility, and Potential Efficacy of Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 45 (actual)
• Sponsor: Johns Hopkins Bloomberg School of Public Health · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

A pilot study to assess the safety, feasibility, and potential (uncontrolled) efficacy of continuous glucose monitoring (CGMS) in conjunction with an insulin pump to improve glycemic control for treatment of type 1 and type 2 diabetic patients with gastroparesis

Detailed description

This multicenter, uncontrolled, open label treatment study is to assess the safety of CGMS in guiding insulin pump therapy for 24 weeks by measuring mild, moderate, and severe hypoglycemic episodes in patients with type 1 and type 2 diabetes and gastroparesis.

Conditions

• Diabetic Gastroparesis

Interventions

Type	Name	Description
DEVICE	CGMS and insulin pump	Use of continuous glucose monitoring system and insulin pump

Timeline

• Start date: 2011-05-01
• Primary completion: 2014-11-01
• Completion: 2015-01-01
• First posted: 2009-12-11
• Last updated: 2022-02-09
• Results posted: 2018-09-04

Locations

7 sites across 1 country: United States